Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107
Sato, Kei, Kunisaki, Chikara, Kosaka, Takashi, Takagawa, Ryo, Takahashi, Masazumi, Izumisawa, Yusuke, Miyamoto, Hiroshi, Sato, Sho, Tanaka, Yusaku, Yamaguchi, Naotaka, Kimura, Jun, Ono, Hidetaka A., MLanguage:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-017-3430-6
Date:
September, 2017
File:
PDF, 595 KB
english, 2017